Additive intraocular pressure lowering effect of various medications with latanoprost

American Journal of Ophthalmology

Volumn 133, Issue 6, 2002, Pages 836-837

  O'Connor, Daniel J ^a   Martone, James F ^b,c   Mead, Alden ^b,c  

^a Post and O'Connor Eye Center   (United States)

^b Eye Center   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; DORZOLAMIDE; LATANOPROST; TIMOLOL;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PSEUDOEXFOLIATION; RETROSPECTIVE STUDY;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; CARBONIC ANHYDRASE INHIBITORS; DRUG SYNERGISM; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; PROSTAGLANDINS F, SYNTHETIC; QUINOXALINES; RETROSPECTIVE STUDIES; SULFONAMIDES; THIOPHENES;

EID: 0036263686     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01418-6     Document Type: Article

References (2)

1. Costs of treating primary open-angle glaucoma and ocular hypertension; a retrospective, observational chart review of newly-diagnosed patients in Sweden and the United States
2. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol; a randomized, observer-masked multicenter study in patients with open-angle glaucoma